title: TNF provokes cardiomyocyte apoptosis and cardiac remodeling through activation of multiple cell death pathways.
abstract: Transgenic mice with cardiac-restricted overexpression of secretable TNF (MHCsTNF) develop progressive LV wall thinning and dilation accompanied by an increase in cardiomyocyte apoptosis and a progressive loss of cytoprotective Bcl-2. To test whether cardiac-restricted overexpression of Bcl-2 would prevent adverse cardiac remodeling, we crossed MHCsTNF mice with transgenic mice harboring cardiac-restricted overexpression of Bcl-2. Sustained TNF signaling resulted in activation of the intrinsic cell death pathway, leading to increased cytosolic levels of cytochrome c, Smac/Diablo and Omi/HtrA2, and activation of caspases -3 and -9. Cardiac-restricted overexpression of Bcl-2 blunted activation of the intrinsic pathway and prevented LV wall thinning; however, Bcl-2 only partially attenuated cardiomyocyte apoptosis. Subsequent studies showed that c-FLIP was degraded, that caspase-8 was activated, and that Bid was cleaved to t-Bid, suggesting that the extrinsic pathway was activated concurrently in MHCsTNF hearts. As expected, cardiac Bcl-2 overexpression had no effect on extrinsic signaling. Thus, our results suggest that sustained inflammation leads to activation of multiple cell death pathways that contribute to progressive cardiomyocyte apoptosis; hence the extent of such programmed myocyte cell death is a critical determinant of adverse cardiac remodeling.
authors: Winters Center for Heart Failure Research, Baylor College of Medicine, Houston, Texas, USA.
authors: Sandra B
authors: SB
authors: Haudek
authors: George E
authors: GE
authors: Taffet
authors: Michael D
authors: MD
authors: Schneider
authors: Douglas L
authors: DL
authors: Mann
mesh_terms: D000818:Animals; D017209:Apoptosis; D020169:Caspases / Q000378:metabolism; D045304:Cytochromes c / Q000378:metabolism; D004789:Enzyme Activation; D006801:Humans; D006984:Hypertrophy / Q000378:metabolism / Q000473:pathology; D051379:Mice; D032383:Myocytes, Cardiac / Q000166:cytology* / Q000378:metabolism*; D019253:Proto-Oncogene Proteins c-bcl-2 / Q000378:metabolism; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism*; D020257:Ventricular Remodeling
chemical_list: D019253:Proto-Oncogene Proteins c-bcl-2; D014409:Tumor Necrosis Factor-alpha; D045304:Cytochromes c; D020169:Caspases
references: Mol Genet Metab. 1998 May;64(1):19-24
references: 9682214
references: Circulation. 1998 Apr 14;97(14):1375-81
references: 9577949
references: Blood. 2004 Dec 1;104(12):3789-96
references: 15280201
references: J Clin Invest. 2005 Mar;115(3):565-71
references: 15765138
references: Circulation. 2005 May 31;111(21):2837-49
references: 15927992
references: Cell. 2000 Jul 7;102(1):1-4
references: 10929706
references: J Biol Chem. 1999 Nov 19;274(47):33267-73
references: 10559201
references: Cell. 2006 Feb 10;124(3):601-13
references: 16469705
references: Circulation. 2000 Oct 3;102(14):1690-6
references: 11015349
references: Clin Invest Med. 2000 Oct;23(5):322-30
references: 11055326
references: J Infect Dis. 2001 Jun 1;183(11):1617-24
references: 11343210
references: Antioxid Redox Signal. 2001 Jun;3(3):403-13
references: 11491653
references: Circulation. 2001 Aug 14;104(7):826-31
references: 11502710
references: Curr Opin Pharmacol. 2001 Apr;1(2):141-50
references: 11714088
references: J Mol Cell Cardiol. 2001 Dec;33(12):2135-44
references: 11735260
references: Am J Physiol Heart Circ Physiol. 2002 Apr;282(4):H1288-95
references: 11893563
references: Proc Natl Acad Sci U S A. 2002 Apr 30;99(9):6252-6
references: 11972044
references: Am J Physiol Heart Circ Physiol. 2002 Jun;282(6):H2316-23
references: 12003842
references: Nat Med. 2002 Jul;8(7):725-30
references: 12053174
references: Cell Death Differ. 2003 Jan;10(1):26-35
references: 12655293
references: J Clin Invest. 2003 May;111(10):1497-504
references: 12750399
references: Circulation. 2003 Jul 29;108(4):407-13
references: 12874181
references: Cell. 2003 Jul 25;114(2):181-90
references: 12887920
references: Circulation. 2003 Dec 16;108(24):3036-41
references: 14638549
references: Proc Natl Acad Sci U S A. 2004 Jan 20;101(3):769-74
references: 14715896
references: Biochim Biophys Acta. 2004 Mar 1;1644(2-3):133-47
references: 14996498
references: Mol Cell. 2004 Apr 9;14(1):81-93
references: 15068805
references: Am J Physiol Cell Physiol. 2004 Sep;287(3):C664-72
references: 15128503
references: Am J Physiol Heart Circ Physiol. 2004 Sep;287(3):H1303-11
references: 15317679
references: Circ Res. 2004 Oct 1;95(7):734-41
references: 15345651
references: Circ Res. 1997 Oct;81(4):627-35
references: 9314845
references: Am J Pathol. 1998 Apr;152(4):897-902
references: 9546350
references: J Exp Med. 1999 Jun 7;189(11):1815-22
references: 10359585